BioFreedom PK Study in Patients With CAD Who Receive the BioFreedom™ Biolimus A9™ Stent
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease
- Focus Pharmacokinetics
- Sponsors Biosensors Europe
- 27 Feb 2018 Planned primary completion date changed from 31 Mar 2018 to 30 Apr 2018.
- 27 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 12 Mar 2018.
- 11 Dec 2017 New trial record